Elgene Lim

37PUBLICATIONS
343CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 12, 2026
Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

|Jun 12, 2026
Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer.

|May 11, 2026
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling.

|Mar 31, 2026
Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer.

Jackson Liang, Christy Ong, Kareem Heslop

|Mar 13, 2026
ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer.

Ann E Collier, Stephanie Hilz, Alejandro M Chibly

|Dec 17, 2025
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA-mutant breast cancer.

Carla L Alves, Leena Karimi, Mikkel G Terp

Pageof 7

Frequent Collaborators

6 joint publications

Alexander Swarbrick

4 joint publications

Aditya Bardia

4 joint publications

Joohyuk Sohn

4 joint publications

Sunny Z Wu